Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi-annual Ivermectin for Epilepsy Prevention in Tanzania
NCT05749653Completed
- Sponsor
- University of Antwerp
- Start
- Mar 2017
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ivermectin in onchocerciasis, sponsored by University of Antwerp. Primary endpoint: Epilepsy incidence at 3 years. Started Mar 2017; status: completed.
02
Drugs
ivermectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT05749653.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05749653.